597 related articles for article (PubMed ID: 27431279)
1. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry.
Xiao L; Pan L; Li B; Zhou Y; Pan Y; Zhang X; Hu Y; Dressler D; Jin L
J Neurol; 2018 Sep; 265(9):2097-2105. PubMed ID: 29987587
[TBL] [Abstract][Full Text] [Related]
3. Subjective and Objective Measures in the Treatment of Hemifacial Spasm With OnabotulinumtoxinA.
Chundury RV; D'Angelo AS; Couch SM; Holds JB
Ophthalmic Plast Reconstr Surg; 2016; 32(2):133-7. PubMed ID: 25811161
[TBL] [Abstract][Full Text] [Related]
4. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
Lolekha P; Choolam A; Kulkantrakorn K
Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
[TBL] [Abstract][Full Text] [Related]
5. Synkinesis in primary and postparalytic hemifacial spasm: Clinical features and therapeutic outcomes of botulinum toxin A treatment.
Su JH; Yang MN; Teng F; Zhang XL; Pan YG; Hu Y; Xiao LB; Pan LZ; Li LX; Jin LJ
Toxicon; 2020 Sep; 184():122-126. PubMed ID: 32553733
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
7. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox).
Couch SM; Chundury RV; Holds JB
Ophthalmic Plast Reconstr Surg; 2014; 30(3):246-50. PubMed ID: 24807539
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
9. A Study on Clinical Profile of Hemifacial Spasm in India and the Therapeutic Response to Botulinum Toxin Type A Injection as well as Pre and Postinjection Quality of Life.
Misra AK; Mukherjee J; Kumar S; Guha G; Mohanty B; Ngullie PS; Manna A; Nanda T; Das AK; Tiwari K
J Assoc Physicians India; 2022 Dec; 70(12):11-12. PubMed ID: 37355970
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.
Tambasco N; Filidei M; Nigro P; Parnetti L; Simoni S
Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941718
[TBL] [Abstract][Full Text] [Related]
11. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
Kilduff CL; Casswell EJ; Salam T; Hersh D; Ortiz-Perez S; Ezra D
JAMA Ophthalmol; 2016 Nov; 134(11):1247-1252. PubMed ID: 27606483
[TBL] [Abstract][Full Text] [Related]
12. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm.
Pandey S; Jain S
Neurol India; 2018; 66(4):1036-1042. PubMed ID: 30038089
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Hemifacial Spasm Grading Scale: a clinical tool for hemifacial spasm.
Tambasco N; Simoni S; Sacchini E; Eusebi P; Marsili E; Nigro P; Brahimi E; Paoletti FP; Romoli M; Calabresi P
Neurol Sci; 2019 Sep; 40(9):1887-1892. PubMed ID: 31076941
[TBL] [Abstract][Full Text] [Related]
16. Does needle size matter? Effects of micro-hypodermic needle injections of botulinum toxin type A in patients with hemifacial spasm.
Maytharakcheep S; Phokaewvarangkul O; Bhidayasiri R
Parkinsonism Relat Disord; 2024 Jan; 118():105950. PubMed ID: 38081119
[TBL] [Abstract][Full Text] [Related]
17. Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm.
Choe WJ; Kim J
Acta Otolaryngol; 2016 Sep; 136(9):952-5. PubMed ID: 27067535
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A is effective to treat tension-type headache caused by hemifacial spasm.
Mizuma A; Nagata E; Yasuda T; Kouchi M; Nakayama T; Honma K; Tokuoka K; Kitagawa Y; Nogawa S; Takizawa S
J Clin Neurosci; 2017 Oct; 44():284-288. PubMed ID: 28734794
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A injection in the treatment of hemifacial spasm.
Chen RS; Lu CS; Tsai CH
Acta Neurol Scand; 1996 Sep; 94(3):207-11. PubMed ID: 8899054
[TBL] [Abstract][Full Text] [Related]
20. The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A.
Kongsaengdao S; Maneeton N; Maneeton B
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33809486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
